Literature DB >> 7513667

Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.

F Lunel1, L Musset, P Cacoub, L Frangeul, P Cresta, M Perrin, P Grippon, C Hoang, D Valla, J C Piette.   

Abstract

BACKGROUND/AIMS: Mixed cryoglobulinemia is frequently associated with liver diseases. The respective role of hepatitis C virus (HCV) and liver damage in the pathogenesis of cryoglobulinemia is investigated in this study.
METHODS: The prevalence of cryoglobulinemia in 226 consecutive patients with chronic liver diseases (hepatitis C, 127; hepatitis B, 40; other diseases, 59) was studied, and the epidemiological, biological, histological, and virological features in these three groups were analyzed. Anti-HCV antibodies, HCV proteins, and HCV RNA were searched in the cryoprecipitates.
RESULTS: The prevalence of mixed cryoglobulinemia was high (41.5%) in patients with liver diseases and higher in patients with hepatitis C (54.3%) than in patients with hepatitis B (15%) or other causes of liver disease (32%). Patients with cryoglobulinemia had cirrhosis more frequently and had a longer history of hepatitis. In patients with hepatitis C, HCV RNA sequences and HCV proteins were detected in the cryoprecipitate. Cryoglobulins became undetectable in 21 of 43 patients treated with interferon.
CONCLUSIONS: These findings suggest that HCV is a major cause of cryoglobulinemia. Besides viral infection itself, multiple factors appear to be responsible for the production of cryoglobulins, including cirrhosis and duration of liver disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513667     DOI: 10.1016/0016-5085(94)90022-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  80 in total

1.  Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity.

Authors:  V Agnello
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

Review 2.  Hepatitis C virus infection and lymphoproliferative disorders.

Authors:  L R Peña; S Nand; N De Maria; D H Van Thiel
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

Review 3.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

4.  Antibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthropathy.

Authors:  M Zehairy; E Soliman; A Daghaidy
Journal:  Rheumatol Int       Date:  2011-11-09       Impact factor: 2.631

Review 5.  Infection-related vasculitis.

Authors:  Omondi Oyoo; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

6.  Natural history of vertically acquired HCV infection and associated autoimmune phenomena.

Authors:  Silvia Garazzino; Carmelina Calitri; Antonella Versace; Alda Alfarano; Carlo Scolfaro; Chiara Bertaina; Simona Vatrano; Federica Mignone; Francesco Licciardi; Clara Gabiano; Pier-Angelo Tovo
Journal:  Eur J Pediatr       Date:  2014-03-04       Impact factor: 3.183

7.  High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy.

Authors:  Giovanni Squadrito; Marcello Previti; Marco Lenzi; Enrico Pagano Le Rose; Gaia Caccamo; Tea Restuccia; Enrico Di Cesare; Teresa Pollicino; Giovanni Raimondo
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

8.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

9.  B cell non-Hodgkin's lymphoma in chronic hepatitis C virus patients: An interesting relationship.

Authors:  Hassan S Hamdy; Nadia A Abdelkader; Amal Mansour; Enas H Allam; Hisham M El-Wakiel; Dina Elshenawy
Journal:  Indian J Gastroenterol       Date:  2015-04-29

10.  The association of complement activation at a low temperature with hepatitis C virus infection in comparison with cryoglobulin.

Authors:  K Ueda; H Nakajima; T Nakagawa; A Shimizu
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.